HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Molecular remission induced by gemtuzumab ozogamicin associated with donor lymphocyte infusions in t(4;11) acute lymphoblastic leukemia relapsed after transplantation.

AuthorsAdriana Balduzzi, Vincenzo Rossi, Lilia Corral, Sonia Bonanomi, Daniela Longoni, Attilio Rovelli, Valentino Conter, Andrea Biondi, Cornelio Uderzo
JournalLeukemia (Leukemia) Vol. 17 Issue 11 Pg. 2247-8 (Nov 2003) ISSN: 0887-6924 [Print] England
PMID12960967 (Publication Type: Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, CD
  • Antigens, Differentiation, Myelomonocytic
  • CD33 protein, human
  • Sialic Acid Binding Ig-like Lectin 3
Topics
  • Antigens, CD (blood)
  • Antigens, Differentiation, Myelomonocytic (blood)
  • Chromosomes, Human, Pair 11
  • Chromosomes, Human, Pair 4
  • Histocompatibility Testing
  • Humans
  • Lymphocyte Transfusion
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma (genetics, immunology, therapy)
  • Recurrence
  • Sialic Acid Binding Ig-like Lectin 3
  • Stem Cell Transplantation
  • Translocation, Genetic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: